PNC Financial Services Group’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-10,958
| Closed | -$931K | – | 4195 |
|
|
2019
Q4 | $931K | Sell |
10,958
-11,415
| -51% | -$761K | ﹤0.01% | 1122 |
|
|
2019
Q3 | $1.12M | Buy |
22,373
+2,620
| +13% | +$105K | ﹤0.01% | 1211 |
|
|
2019
Q2 | $721K | Buy |
19,753
+3,925
| +25% | +$128K | ﹤0.01% | 1430 |
|
|
2019
Q1 | $442K | Buy |
15,828
+1,444
| +10% | +$34K | ﹤0.01% | 1700 |
|
|
2018
Q4 | $275K | Sell |
14,384
-302
| -2% | -$7.03K | ﹤0.01% | 1876 |
|
|
2018
Q3 | $439K | Buy |
14,686
+1,591
| +12% | +$59.9K | ﹤0.01% | 1744 |
|
|
2018
Q2 | $481K | Buy |
13,095
+2,550
| +24% | +$82.9K | ﹤0.01% | 1679 |
|
|
2018
Q1 | $348K | Buy |
10,545
+2,398
| +29% | +$74.9K | ﹤0.01% | 1839 |
|
|
2017
Q4 | $224K | Sell |
8,147
-1,462
| -15% | -$45K | ﹤0.01% | 2131 |
|
|
2017
Q3 | $356K | Buy |
9,609
+1,239
| +15% | +$45.7K | ﹤0.01% | 1812 |
|
|
2017
Q2 | $318K | Buy |
8,370
+6,261
| +297% | +$279K | ﹤0.01% | 1860 |
|
|
2017
Q1 | $104K | Buy |
2,109
+1,631
| +341% | +$74.4K | ﹤0.01% | 2471 |
|
|
2016
Q4 | $16K | Buy |
478
+6
| +1% | +$213 | ﹤0.01% | 3331 |
|
|
2016
Q3 | $18K | Sell |
472
-381
| -45% | -$14.4K | ﹤0.01% | 3282 |
|
|
2016
Q2 | $29K | Sell |
853
-5,214
| -86% | -$184K | ﹤0.01% | 3097 |
|
|
2016
Q1 | $193K | Sell |
6,067
-9,786
| -62% | -$320K | ﹤0.01% | 2148 |
|
|
2015
Q4 | $592K | Sell |
15,853
-20
| -0.1% | -$756 | ﹤0.01% | 1441 |
|
|
2015
Q3 | $603K | Buy |
15,873
+33
| +0.2% | +$1.16K | ﹤0.01% | 1454 |
|
|
2015
Q2 | $453K | Buy |
15,840
+168
| +1% | +$4.68K | ﹤0.01% | 1683 |
|
|
2015
Q1 | $440K | Buy |
15,672
+14,900
| +1,930% | +$419K | ﹤0.01% | 1722 |
|
|
2014
Q4 | $23K | Sell |
772
-18,005
| -96% | -$446K | ﹤0.01% | 3105 |
|
|
2014
Q3 | $419K | Hold |
18,777
| – | – | ﹤0.01% | 1582 |
|
|
2014
Q2 | $546K | Buy |
18,777
+160
| +0.9% | +$4.27K | ﹤0.01% | 1400 |
|
|
2014
Q1 | $529K | Sell |
18,617
-2,851
| -13% | -$94.3K | ﹤0.01% | 1373 |
|
|
2013
Q4 | $828K | Buy |
21,468
+1,883
| +10% | +$67.3K | ﹤0.01% | 1116 |
|
|
2013
Q3 | $656K | Buy |
19,585
+9,400
| +92% | +$299K | ﹤0.01% | 1197 |
|
|
2013
Q2 | $314K | Buy |
+10,185
| New | +$341K | ﹤0.01% | 1550 |
|
Other funds holding MDCO
PNC Financial Services Group's MDCO Position: Q1 2020 in Review
PNC Financial Services Group sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 10,958 shares — an estimated $931K sold.
PNC Financial Services Group first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $1.12M in Q3 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- PNC Financial Services Group reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- PNC Financial Services Group sold 10,958 Medicines Co shares in Q1 2020, an estimated $931K.
- PNC Financial Services Group first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
- PNC Financial Services Group's Medicines Co position peaked at $1.12M in Q3 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on PNC Financial Services Group's 13F filing for Q1 2020, filed 8 May 2020.